Suppr超能文献

通过转录组学和蛋白质组学揭示帕金森病小鼠模型中的线粒体功能障碍。

Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics.

机构信息

Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, CHS 23-120, Box 951735, Los Angeles, CA 90095-1735, USA.

出版信息

J Bioenerg Biomembr. 2009 Dec;41(6):487-91. doi: 10.1007/s10863-009-9254-2.

Abstract

It has been long thought that neuronal loss in Parkinson's disease (PD) is related to reactive oxygen species from mitochondrial dysfunction. However, there have been few investigations surveying both transcriptome and proteome in PD. This review focuses on recent work using microarrays and mass spectrometry to examine neurotoxicological models of PD in the mouse. Molecular pathways involved in oxidative phosphorylation, oxidative stress, apoptosis/cell death, signal transduction and neurotransmission were highlighted. Analysis of tyrosine nitration suggested that this important post-translational modification, due to conjugation of reactive oxygen species with nitric oxide, may play an important role in signal transduction as well as the molecular pathology of PD. Thus, the combined investigations highlight known pathways in PD but also point to new directions for research, implicating particularly the role of relatively understudied classes of post-translational modifications in normal cell signaling and neurological disorders.

摘要

长期以来,人们一直认为帕金森病 (PD) 中的神经元丧失与线粒体功能障碍产生的活性氧有关。然而,针对帕金森病的转录组和蛋白质组进行调查的研究却很少。本综述重点介绍了使用微阵列和质谱法研究 PD 小鼠神经毒理学模型的最新工作。重点介绍了涉及氧化磷酸化、氧化应激、细胞凋亡/死亡、信号转导和神经递质传递的分子途径。酪氨酸硝化分析表明,这种由于活性氧与一氧化氮结合而导致的重要的翻译后修饰可能在信号转导以及 PD 的分子病理学中发挥重要作用。因此,综合研究不仅突出了 PD 中的已知途径,还为研究指明了新的方向,特别涉及相对研究较少的翻译后修饰类别在正常细胞信号和神经紊乱中的作用。

相似文献

1
Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics.
J Bioenerg Biomembr. 2009 Dec;41(6):487-91. doi: 10.1007/s10863-009-9254-2.
3
New insights on the mitochondrial proteome plasticity in Parkinson's disease.
Proteomics Clin Appl. 2016 Apr;10(4):416-29. doi: 10.1002/prca.201500092. Epub 2016 Feb 24.
6
Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
Antioxid Redox Signal. 2012 May 1;16(9):896-919. doi: 10.1089/ars.2011.4200. Epub 2011 Oct 4.
7
Mitochondrial quality control and Parkinson's disease: a pathway unfolds.
Mol Neurobiol. 2011 Apr;43(2):80-6. doi: 10.1007/s12035-010-8150-4. Epub 2010 Dec 1.
8
Neuroprotective role of CHCHD2 in Parkinson's disease: Insights into the GPX4-related ferroptosis pathway.
Free Radic Biol Med. 2025 Jan;226:348-363. doi: 10.1016/j.freeradbiomed.2024.11.034. Epub 2024 Nov 19.
9
Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease.
Free Radic Res. 2011 Jan;45(1):53-8. doi: 10.3109/10715762.2010.509398. Epub 2010 Sep 6.
10
The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
J Neurochem. 2021 Mar;156(6):715-752. doi: 10.1111/jnc.15154. Epub 2020 Sep 20.

引用本文的文献

1
Protein Tyrosine Amination: Detection, Imaging, and Chemoproteomic Profiling with Synthetic Probes.
J Am Chem Soc. 2024 May 1;146(17):11944-11954. doi: 10.1021/jacs.4c01028. Epub 2024 Apr 15.
2
Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson's disease.
Transl Neurosci. 2022 Sep 1;13(1):255-269. doi: 10.1515/tnsci-2022-0237. eCollection 2022 Jan 1.
3
The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach.
J Mol Neurosci. 2019 Jan;67(1):150-164. doi: 10.1007/s12031-018-1220-1. Epub 2018 Dec 15.
4
Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.
Expert Rev Proteomics. 2016;13(3):259-74. doi: 10.1586/14789450.2016.1149470.
5
Emerging candidate biomarkers for Parkinson's disease: a review.
Aging Dis. 2013 Oct 9;5(1):27-34. doi: 10.14366/AD.2014.050027. eCollection 2014 Feb.
6
Cerebrospinal fluid biomarker candidates for parkinsonian disorders.
Front Neurol. 2013 Jan 21;3:187. doi: 10.3389/fneur.2012.00187. eCollection 2012.
7
Comparative mitochondrial proteomics: perspective in human diseases.
J Hematol Oncol. 2012 Mar 18;5:11. doi: 10.1186/1756-8722-5-11.
9
Nutrient-enhanced diet reduces noise-induced damage to the inner ear and hearing loss.
Transl Res. 2011 Jul;158(1):38-53. doi: 10.1016/j.trsl.2011.02.006. Epub 2011 Mar 21.
10
Factors influencing protein tyrosine nitration--structure-based predictive models.
Free Radic Biol Med. 2011 Mar 15;50(6):749-62. doi: 10.1016/j.freeradbiomed.2010.12.016. Epub 2010 Dec 21.

本文引用的文献

1
Oxidative and nitrosative stress in Parkinson's disease.
Biochim Biophys Acta. 2009 Jul;1792(7):643-50. doi: 10.1016/j.bbadis.2008.12.006. Epub 2008 Dec 30.
2
Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.
Ann N Y Acad Sci. 2008 Dec;1147:93-104. doi: 10.1196/annals.1427.023.
4
Accurate mass measurements in proteomics.
Chem Rev. 2007 Aug;107(8):3621-53. doi: 10.1021/cr068288j. Epub 2007 Jul 25.
5
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
Nature. 2006 Oct 19;443(7113):787-95. doi: 10.1038/nature05292.
6
Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease.
Biochemistry. 2006 Jul 4;45(26):8009-22. doi: 10.1021/bi060474w.
8
Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.
J Proteome Res. 2006 Feb;5(2):262-9. doi: 10.1021/pr050281f.
9
Advances in proteomics data analysis and display using an accurate mass and time tag approach.
Mass Spectrom Rev. 2006 May-Jun;25(3):450-82. doi: 10.1002/mas.20071.
10
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19126-31. doi: 10.1073/pnas.0508215102. Epub 2005 Dec 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验